Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function - Test2 - elhamkhani - TriplyDB

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

http://www.wikidata.org/entity/Q23920947

about

Gpnmb is a melanoblast-expressed, MITF-dependent gene Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity Growth and repair factors, osteoactivin, matrix metalloproteinase and heat shock protein 72, increase with resolution of inflammation in musculotendinous tissues in a rat model of repetitive grasping Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping Genomic analysis of wig-1 pathways Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.Replicative senescence of mesenchymal stem cells: a continuous and organized process Exploratory study on the effect of osteoactivin on muscle regeneration in a rat volumetric muscle loss model Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation.Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo Role of human HGFIN/nmb in breast cancer Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells.Different effects on bone strength and cell differentiation in pre pubertal caloric restriction versus hypothalamic suppression.PPARG by dietary fat interaction influences bone mass in mice and humans.Emerging therapeutic targets in breast cancer bone metastasis.Management of metastatic breast cancer with second-generation antibody-drug conjugates: focus on glembatumumab vedotin (CDX-011, CR011-vcMMAE).Prospects of osteoactivin in tissue regeneration.Osteoactivin promotes osteoblast adhesion through HSPG and αvβ1 integrin.Osteoactivin induces transdifferentiation of C2C12 myoblasts into osteoblasts.Comparison of bone morphogenetic protein-2 and osteoactivin for mesenchymal cell differentiation: effects of bolus and continuous administration.Wdr5 is essential for osteoblast differentiation.Upregulation of monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) expression in end-stage renal disease.Effects of GPNMB on proliferation and odontoblastic differentiation of human dental pulp cells.Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes.Exploratory study on the effect of osteoactivin on bone formation in the rat critical-size calvarial defect model.Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering.GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: potential role for tissue engineering bone.Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts.Gene expression during long-term culture of mesenchymal stem cells obtained from patients with amyotrophic lateral sclerosis Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease.

P2860

Q24646177-3E944CDE-797D-4C16-B053-95C27961FAF5 Q28274725-178A7DD6-B705-45B6-A520-D3FCD191A4F4 Q28384478-B3AAF14A-CBC5-4E4E-98C6-5ED763955499 Q28384638-EC3AEE09-A690-4F2C-84AF-8C78EBDAAC27 Q28732207-A0A494F1-27D0-49F6-9347-6A814BE930D2 Q30417516-9C20C1F5-5775-4A57-AE52-6AA6F985D4D1 Q33336408-A32AAB5C-C265-45D9-B5F8-23A676576770 Q33584788-5CA5545C-0A99-404D-A8FC-DB79FBB8887D Q34247178-ABE5DF84-E4FE-44B3-838A-4A49B780CAC3 Q35953074-963E16D3-2942-487D-8FAB-ED1A22EA42CD Q36026788-1F67AE02-4514-4113-A334-427ECB358A1D Q36103227-1FEE9C96-8D60-49AA-A89F-26D0F1BA7BD3 Q36458735-393F2186-46CB-44B7-84CE-495FE660C1EF Q36724904-AF15C657-5B6E-4BA9-8FF0-CE3A7412F7F7 Q37014479-B4589F3B-D66D-4E6C-98F2-8F69CCCEA1BC Q37046492-F1022107-1D9C-4D8E-BEA9-7871F7A14810 Q37168301-A96D7A9E-5580-4F7A-ADAC-7E9AC4B84F4E Q37194911-4A8D8158-80F6-44F6-92D1-81FDC932F9AF Q37658767-2E829016-5712-42B4-ACD3-8D5282A31532 Q38185304-681775D3-E4E6-4A03-A023-F168191208BE Q38843273-0D15C00E-1882-48E1-9E39-EC2CBB0F611C Q39035204-5A3E5A99-7334-4D01-AAAC-8771896AA833 Q39058566-6B9886CD-025E-48D6-8EE2-5A84DD856E33 Q39596165-382D7643-CEB8-41AC-ABA1-C1982D987A48 Q40024093-15130C09-5740-4724-881F-DF4762130774 Q42217742-760410D0-016E-4EBE-8EBE-C629A97569DE Q42418460-392346A0-4333-4B07-B41E-4588643B043B Q43106630-DFBFF89B-B330-453F-92F5-5D3C3B64A6BF Q47343235-DC33C547-D461-4147-8DF7-988CD3EEBCB2 Q47448408-7A079979-0392-4E76-B93E-5F7ADC8837B5 Q48828725-3D4057FA-BBB5-47C8-9FBB-6B72813775D7 Q50883871-A37ABA47-DB36-49FC-BEB2-D8693135F33C Q52610201-68E33C67-E128-48FE-AF7D-0AEC8AC8A143 Q53176364-DE42C03B-C754-4B7F-BA79-B3E9E34985CC Q53540627-181EDEAC-6414-4A3D-BE0F-FAEE17C0049F

P2860

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

http://www.wikidata.org/entity/Q23920947

description

2006 nî lūn-bûn

@nan

2006 թուականին հրատարակուած գիտական յօդուած

@hyw

2006 թվականին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@ast

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en-gb

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@nl

type

label

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@ast

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en-gb

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@nl

prefLabel

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@ast

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en-gb

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@nl

P1433

Q23920947-AD45054B-E340-468E-BD50-F77273B4A955

P1476

Q23920947-EB7960BC-2FD6-4194-B317-66D2D7863023

P2093

Q23920947-2CFB3E93-7FAA-41C7-97A0-D9BD8917B645

Q23920947-A94AE410-FF86-411F-AD8F-77CB675522E8

Q23920947-C5E9E980-33C4-4340-A61B-F8FAA65164DE

Q23920947-D854D832-13F8-40DE-8089-2A67D820560C

Q23920947-F0C04949-E620-4F2A-B561-A44C562C1FCA

Q23920947-FCE42BF4-3B3A-49D3-A2CE-6BD1E00903FD

P2860

Q23920947-BF93BC2E-558C-452A-A98C-F129646898EF

Q23920947-DC353BD9-D4CA-4476-B1B8-43D4126D92C7

P2880

Q23920947-99E43637-729B-4AE1-8448-55FC3990C6EC

P304

Q23920947-D7A6AA11-1D81-44DC-AD54-3B21186DADC8

P31

Q23920947-951C0C76-ACC8-40E6-A681-8C7B182293CB

P356

Q23920947-1C85CDB7-733C-4A6C-BFC4-278286E2F99A

P407

Q23920947-B17472AF-712F-49BC-8D62-955418F7B18B

P433

Q23920947-5FD8568D-8CEB-4578-BAB1-1E24FD0594FE

P478

Q23920947-ED03211E-7AA9-4A76-AC99-98F7E5FA4D31

P577

Q23920947-D773CA6C-2961-4D23-9D36-06AB38F9F860

P5875

Q23920947-0A87E67F-9175-43E9-B5AD-BEDD612F27E0

P698

Q23920947-3C5546ED-9AF2-497E-B87A-2C926AF13886

P859

Q23920947-A97655EA-4908-4A9A-9ED4-8A9CFCCF4867

P921

Q23920947-71628BFA-E293-43F0-8641-7202346425C8

Q23920947-99966F64-1232-4F21-9D06-D90BC1274645

Q23920947-A608C4C4-4FF0-4A48-98C7-8DCA63B227F8

Q23920947-B0A6EB24-BEE9-45F8-99C8-46182E4518EA

P356

P1433

Journal of Cellular Physiology

P1476

Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function

@en

P2093

Fayez F. Safadi

http://www.w3.org/2001/XMLSchema#string

Israel Arango-Hisijara

http://www.w3.org/2001/XMLSchema#string

Mary F. Barbe

http://www.w3.org/2001/XMLSchema#string

Samir M. Abdelmagid

http://www.w3.org/2001/XMLSchema#string

Steven N. Popoff

http://www.w3.org/2001/XMLSchema#string

Thomas A. Owen

http://www.w3.org/2001/XMLSchema#string

P2860

Pmel17 initiates premelanosome morphogenesis within multivesicular bodies

The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult.

P2880

20041716

http://www.w3.org/2001/XMLSchema#string

P304

26-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.20841

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

210

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6761345

http://www.w3.org/2001/XMLSchema#string

P698

17034042

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

dose–response relationship